Post-Policy Implementation Review of Rapid Fetal Fibronectin (fFN) Testing for Preterm Labour in Alberta

Chuck, Anderson; Thanh, Nguyen Xuan; Chari, Radha; Wilson, R. Douglas; Janes-Kelley, Selikke; Wesenberg, James C.

doi:10.1016/j.jogc.2016.02.013

Cited by 11 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two studies compared and combined fFN with CL as a predictor of a PTB in asymptomatic women, and both found fFN to be a superior test [85][86][87]. However, others have demonstrated that fFN results alone are not useful [88][89][90]. In a systematic review [91] of six randomized trials in which a total of 546 women with threatened preterm labor were randomly assigned to management with reported or concealed fFN results, clinician knowledge of their fFN results did not reduce the rates of maternal hospitalization or a PTB at <34 weeks of gestation.…”

Section: Fetal Fibronectin (Ffn)mentioning

confidence: 99%

Cervical Assessment for Predicting Preterm Birth—Cervical Length and Beyond

Reicher

Fouks

Yogev

2021

JCM

View full text Add to dashboard Cite

Preterm birth is considered one of the main etiologies of neonatal death, as well as short- and long-term disability worldwide. A number of pathophysiological processes take place in the final unifying factor of cervical modifications that leads to preterm birth. In women at high risk for preterm birth, cervical assessment is commonly used for prediction and further risk stratification. This review outlines the rationale for cervical length screening for preterm birth prediction in different clinical settings within existing and evolving new technologies to assess cervical remodeling.

show abstract

Section: Fetal Fibronectin (Ffn)mentioning

confidence: 99%

Cervical Assessment for Predicting Preterm Birth—Cervical Length and Beyond

Reicher

Fouks

Yogev

2021

JCM

View full text Add to dashboard Cite

show abstract

ISUOGPractice Guidelines: role of ultrasound in the prediction of spontaneous preterm birth

Coutinho

Sotiriadis

Odibo

et al. 2022

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

and Gynecology (ISUOG) is a scientific organization that encourages sound clinical practice and high-quality teaching and research related to diagnostic imaging in women's healthcare. The ISUOG Clinical Standards Committee (CSC) has a remit to develop Practice Guidelines and Consensus Statements as educational recommendations that provide healthcare practitioners with a consensus-based approach, from experts, for diagnostic imaging. They are intended to reflect what is considered by ISUOG to be the best practice at the time at which they are issued. Although ISUOG has made every effort to ensure that Guidelines are accurate when issued, neither the Society nor any of its employees or members accepts liability for the consequences of any inaccurate or misleading data, opinions or statements issued by the CSC. The ISUOG CSC documents are not intended to establish a legal standard of care, because interpretation of the evidence that underpins the Guidelines may be influenced by individual circumstances, local protocol and available resources. Approved Guidelines can be distributed freely with the permission of ISUOG (

show abstract